Approval · Notice of Compliance 38354 · 2026
PROVOCHOLINE: Notice of Compliance 38354
Issued September 25, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 38354
- Date
- September 25, 2026
- Company
- Methapharm Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a drug product manufacturing site and/or manufacturer involving production. New package labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PROVOCHOLINE | Not yet assigned | — |
| PROVOCHOLINE INHALATION SOLUTION | Not yet assigned | — |
| PROVOCHOLINE INHALATION SOLUTION 16 | 02571870 | Approved |
Medicinal ingredients
- METHACHOLINE CHLORIDE 160 MG per VIAL
- METHACHOLINE CHLORIDE 1,280 MG per VIAL
- METHACHOLINE CHLORIDE 320 MG per VIAL
- METHACHOLINE CHLORIDE 1,600 MG per VIAL
- METHACHOLINE CHLORIDE 100 MG per VIAL
- METHACHOLINE CHLORIDE 0.0625 MG per ML
- METHACHOLINE CHLORIDE 0.25 MG per ML
- METHACHOLINE CHLORIDE 1 MG per ML
- METHACHOLINE CHLORIDE 4 MG per ML
- METHACHOLINE CHLORIDE 16 MG per ML